Видео ютуба по тегу Surrogate Endpoints

Biomarkers and Surrogate Endpoints in Drug Development
Biomarkers and Surrogate Endpoints in Drug Development
endpoints, clinical trial outcomes, & surrogate endpoints
endpoints, clinical trial outcomes, & surrogate endpoints
Use of Surrogate Endpoints in Oncology
Use of Surrogate Endpoints in Oncology
Advancing Treatment Evaluation With Surrogate EndPoints in MPNs
Advancing Treatment Evaluation With Surrogate EndPoints in MPNs
25 SurrogateEndpoints
25 SurrogateEndpoints
Lecture 2 - Surrogate Endpoints in Oncology - Reading and Interpreting Cancer Trials
Lecture 2 - Surrogate Endpoints in Oncology - Reading and Interpreting Cancer Trials
Advanced Webinar: The Statistical Evaluation of Surrogate Endpoints in Clinical Trials - EJP RD
Advanced Webinar: The Statistical Evaluation of Surrogate Endpoints in Clinical Trials - EJP RD
Validating Surrogate Endpoints in Oncology
Validating Surrogate Endpoints in Oncology
Surrogate Endpoints
Surrogate Endpoints
Statistical Considerations on the Use of Surrogate Endpoints | Thomas Fleming
Statistical Considerations on the Use of Surrogate Endpoints | Thomas Fleming
Surrogate endpoints | What do they mean?
Surrogate endpoints | What do they mean?
Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 2
Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 2
Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 1
Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 1
Biomarker validation as surrogate endpoints for drug approval
Biomarker validation as surrogate endpoints for drug approval
The use of surrogate endpoints in CLL clinical trials
The use of surrogate endpoints in CLL clinical trials
What Is The Difference Between Surrogate And True Clinical Endpoints?
What Is The Difference Between Surrogate And True Clinical Endpoints?
Surrogate Endpoints for New Drug Discovery in Acute Lymphoblastic Leukemia
Surrogate Endpoints for New Drug Discovery in Acute Lymphoblastic Leukemia
Can CSF biomarkers serve as surrogate endpoints in clinical trials?
Can CSF biomarkers serve as surrogate endpoints in clinical trials?
Surrogate Endpoints in Transplant Research - Kelsey Lloyd
Surrogate Endpoints in Transplant Research - Kelsey Lloyd
Brad Glasscock | PKU Case Study: Use of Surrogate Endpoints
Brad Glasscock | PKU Case Study: Use of Surrogate Endpoints
The value of surrogate endpoints in the benefit-risk assessment of new drugs | Gabe Sonke, MD, PhD
The value of surrogate endpoints in the benefit-risk assessment of new drugs | Gabe Sonke, MD, PhD
Surrogate Endpoints in Solid and Liquid Tumors
Surrogate Endpoints in Solid and Liquid Tumors
GAO surrogate endpoints
GAO surrogate endpoints
Health Plan Take on the Cancer Drug Approval Process and Surrogate Endpoints
Health Plan Take on the Cancer Drug Approval Process and Surrogate Endpoints
GFR Decline as a Surrogate Endpoint for Progression of Chronic Kidney Disease
GFR Decline as a Surrogate Endpoint for Progression of Chronic Kidney Disease